Moreover, SIRT1 inhibits neurodegeneration in in vivo and in vitro models of Alzheimer's disease, amyotrophic lateral sclerosis (ALS), and Wallerian degeneration [14–17]. Here, SIRT1 is linked to amyotrophic lateral sclerosis.